Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment

BACKGROUND: Bridging treatments are employed in liver transplant waitlist patients with hepatocellular carcinoma (HCC) because of the risk of tumor progression during the waiting time. Radioembolization is mostly employed in the control of large or multifocal HCCs when other locoregional treatment m...

Descripción completa

Detalles Bibliográficos
Autores principales: Radunz, Sonia, Treckmann, Jürgen, Baba, Hideo A., Best, Jan, Müller, Stefan, Theysohn, Jens M., Paul, Andreas, Benkö, Tamás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248013/
https://www.ncbi.nlm.nih.gov/pubmed/28408731
http://dx.doi.org/10.12659/AOT.902595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248013/
https://www.ncbi.nlm.nih.gov/pubmed/28408731
http://dx.doi.org/10.12659/AOT.902595

Ejemplares similares